CXCL2



CXCL2

A1AA1V2VV2V3VV3A4AA4S5SS5E6EE6L7LL7R8RR8C9CC9Q10QQ10C11CC11L12LL12K13KK13T14TT14L15LL15P16PP16R17RR17V18VV18D19DD19F20FF20K21KK21N22NN22I23II23Q24QQ24S25SS25L26LL26S27SS27V28VV28T29TT29P30PP30P31PP31G32GG32P33PP33H34HH34C35CC35A36AA36Q37QQ37T38TT38E39EE39V40VV40I41II41A42AA42T43TT43L44LL44K45KK45G46GG46G47GG47... and 26 more residue(s)...... and 26 more residue(s)

SMILES None
InChIKey None
Sequence AVVASELRCQCLKTLPRVDFKNIQSLSVTPPGPHCAQTEVIATLKGGQKVCLDPEAPLVQKIIQKILNKGKAN

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



No bioactivity data available.

CXCL2

A1AA1V2VV2V3VV3A4AA4S5SS5E6EE6L7LL7R8RR8C9CC9Q10QQ10C11CC11L12LL12K13KK13T14TT14L15LL15P16PP16R17RR17V18VV18D19DD19F20FF20K21KK21N22NN22I23II23Q24QQ24S25SS25L26LL26S27SS27V28VV28T29TT29P30PP30P31PP31G32GG32P33PP33H34HH34C35CC35A36AA36Q37QQ37T38TT38E39EE39V40VV40I41II41A42AA42T43TT43L44LL44K45KK45G46GG46G47GG47... and 26 more residue(s)...... and 26 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.